Private Advisor Group LLC Sells 27 Shares of Chemed Co. (NYSE:CHE)

Private Advisor Group LLC decreased its position in shares of Chemed Co. (NYSE:CHEFree Report) by 3.3% in the 4th quarter, HoldingsChannel reports. The firm owned 803 shares of the company’s stock after selling 27 shares during the quarter. Private Advisor Group LLC’s holdings in Chemed were worth $425,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. CIBC Asset Management Inc raised its stake in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after acquiring an additional 22 shares in the last quarter. EP Wealth Advisors LLC raised its stake in Chemed by 1.9% during the third quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after acquiring an additional 25 shares in the last quarter. First Heartland Consultants Inc. raised its stake in Chemed by 7.2% during the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares in the last quarter. KBC Group NV raised its stake in Chemed by 11.5% during the third quarter. KBC Group NV now owns 378 shares of the company’s stock worth $227,000 after acquiring an additional 39 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Activity

In other news, VP Brian C. Judkins acquired 145 shares of the stock in a transaction dated Monday, December 30th. The stock was bought at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This represents a 9.46 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 3.32% of the stock is currently owned by insiders.

Chemed Price Performance

Chemed stock opened at $588.93 on Tuesday. The business has a 50 day moving average of $546.69 and a 200-day moving average of $563.35. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $654.62. The company has a market capitalization of $8.86 billion, a P/E ratio of 29.76, a P/E/G ratio of 2.15 and a beta of 0.48.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.34%. The ex-dividend date is Monday, February 24th. Chemed’s dividend payout ratio is currently 10.05%.

Wall Street Analyst Weigh In

Several brokerages have commented on CHE. Royal Bank of Canada lowered their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th. StockNews.com downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Thursday, February 27th.

Get Our Latest Report on CHE

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.